Literature DB >> 16925570

Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature.

N G Almyroudis1, D A Sutton, P Linden, M G Rinaldi, J Fung, S Kusne.   

Abstract

Zygomycetes are ubiquitous fungi that can cause invasive disease associated with high mortality. We report 10 solid organ transplant recipients with zygomycosis (incidence 2 per 1000) and reviewed 106 cases in the English-language literature. These included renal (n = 73), heart (n = 16), lung (n = 4), heart/lung (n = 2), liver (n = 19) and kidney/pancreas (n = 2) transplant recipients. All patients were receiving immunosuppression and the vast majority steroids. The clinical presentation included rhino-sino-orbital (n = 20), rhinocerebral (n = 16), pulmonary (n = 28), gastrointestinal (n = 13), cutaneous (n = 18), renal (n = 6) and disseminated disease (n = 15). Most frequently isolated genera were Rhizopus (73%) followed by Mucor (13%). The overall mortality was 49%. While rhino-sino-orbital disease had the best prognosis, rhinocerebral disease had high mortality (93%) comparable to disseminated disease. A favorable outcome was associated with limited, surgically accessible disease and early surgical intervention along with amphotericin B administration.

Entities:  

Mesh:

Year:  2006        PMID: 16925570     DOI: 10.1111/j.1600-6143.2006.01496.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  54 in total

1.  Mucormycosis in Mato Grosso, Brazil: a case reports, caused by Rhizopus microsporus var. oligosporus and Rhizopus microsporus var. rhizopodiformis.

Authors:  Luciano Corrêa Ribeiro; Bodo Wanke; Manuela da Silva; Luciana Basili Dias; Renato Mello; Fernando Artur Pena Borges Canavarros; Diniz Pereira Leite; Rosane Christine Hahn
Journal:  Mycopathologia       Date:  2011-09-28       Impact factor: 2.574

2.  In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.

Authors:  Nikolaos G Almyroudis; Deanna A Sutton; Annette W Fothergill; Michael G Rinaldi; Shimon Kusne
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

3.  Predisposing Factors for Mucormycosis in Patients with Diabetes Mellitus; An Experience of 21 Years in Southern Iran.

Authors:  Amene S Sarvestani; Gholamreza Pishdad; Shahram Bolandparvaz
Journal:  Bull Emerg Trauma       Date:  2013-10

4.  Colonic mucormycosis presented with ischemic colitis in a liver transplant recipient.

Authors:  Gi Won Do; Seok Won Jung; Jae-Bum Jun; Jae Hee Seo; Yang Won Nah
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 5.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

6.  Zygomycosis: an emerging fungal infection with new options for management.

Authors:  Carol A Kauffman; Anurag N Malani
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

7.  Internal transcribed spacer region sequence heterogeneity in Rhizopus microsporus: implications for molecular diagnosis in clinical microbiology laboratories.

Authors:  Patrick C Y Woo; Shui-Yee Leung; Kelvin K W To; Jasper F W Chan; Antonio H Y Ngan; Vincent C C Cheng; Susanna K P Lau; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

Review 8.  Emerging fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

9.  Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

Authors:  Cornelia Lass-Flörl; Astrid Mayr; Susanne Perkhofer; Guido Hinterberger; Johann Hausdorfer; Cornelia Speth; Manfred Fille
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

10.  Gastrointestinal mucormycosis--four cases with different risk factors, involving different anatomical sites.

Authors:  Shailendra Lalwani; Mahendran Govindasamy; Manoj Gupta; Fouzia Siraj; Vibha Varma; Naimaish Mehta; Vinay Kumaran; Neelam Mohan; Prem Chopra; Anil Arora; Shyam Agarwal; Arvinder Soin; Samiran Nundy
Journal:  Indian J Gastroenterol       Date:  2012-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.